A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection

Clinical trial NCT02604017 · COMPLETED

Trial details

NCT number: NCT02604017
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hepatitis C Hepatitis C Virus HCV

Start date: 2015-10-01
Primary completion: 2017-01-01
Enrollment: 703

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.